[ad_1] NEW YORK (AP) — Drugmaker Bristol Myers Squibb is acquiring Karuna Therapeutics, a biopharmaceutical company that has developed a new antipsychotic, in a $14 billion deal. Bristol Myers Squibb…
Tag: Myers
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
[ad_1] Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock popped more than 47%…
Director, Marketing Excellence-Talent Strategy & Development at Bristol Myers Squibb
[ad_1] Bristol Myers Squibb, Princeton, New Jersey, United States, Work at Bristol Myers Squibb **Working with Us**Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But…
Fort Myers small businesses kick off holiday donation drive for local nonprofit
[ad_1] Salty Papa’s Shrimp House and Sunset Builders & Maintenance are asking for the community’s participation in their first annual Holiday Drive to benefit the RYAN…
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
[ad_1] Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug…
Test vacancy in one of his buildings on First Street in Fort Myers, Fla. He partnered with restaurant industry veterans vacancy in one of his buildings on First Street in Fort Myers, Fla. He partnered with restaurant industry veterans | Long Island Business News
[ad_1] Test vacancy in one of his buildings on First Street in Fort Myers, Fla … Long Island Business News [ad_2] Source link
Fortnite’s Fortnitemares Event to Add Jack Skellington and Michael Myers to the Game
[ad_1] Fortnite‘s Fortnitemares event will bring seasonal skins of The Nightmare Before Christmas’ Jack Skellington and Halloween’s Michael Myers to the game. The Shape of Fortnitemares 2023 The seasonal Halloween…
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
[ad_1] The deal expands the pharmaceutical company’s portfolio of cancer drugs. [ad_2] Source link
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
[ad_1] Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value Right Acquisition Brings KRAZATI® (adagrasib), a…